John Nemunaitis, MD
John Nemunaitis, MD
MD
Gradalis, Inc.
2001 Bryan St
Ste 2050
Dallas,
TX
USA
75201
Papers:
1
Randomized phase II trial of maintenance autologous tumor cell vaccine (FANG™) following clinical complete response (cCR) in stage III/IV ovarian cancer: preliminary results